Label: CHILDRENS ALLERGY RELIEF- cetirizine hydrochloride solution

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 15, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT(S)

    (in each 5 mL)
    Cetirizine Hydrochloride USP 5mg


  • PURPOSE

    Antihistamine

  • USE(S)

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:


    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat
  • WARNINGS

  • DO NOT USE

    if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

  • ASK A DOCTOR BEFORE USE IF

    you have liver or kidney disease. Your doctor should determine if you need a different dose.

  • ASK A DOCTOR OR PHARMACIST BEFORE USE IF

    you are taking tranquilizers or sedatives.

  • WHEN USING THIS PRODUCT

    • drowsiness may occur      
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery
  • STOP USE AND ASK A DOCTOR IF

    an allergic reaction to this product occurs. Seek medical help right away.

  • If pregnant or breast-feeding


    • if breast-feeding: not recommended
    • if pregnant: ask a health professional before use.
  • KEEP OUT OF REACH OF CHILDREN


    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • DIRECTIONS


    • use only with enclosed dosing cup
    • find right dose on chart below
    • mL = milliliter


    adults and children 6 years and over
    		5 mL or 10 mL once daily depending upon severity of symptoms; do not take more than 10 mL in 24 hours.
    adults 65 years and over
    		5 mL once daily; do not take more than 5 mL in                  24 hours.
    children 2 to under 6 years of age
    		2.5 mL once daily. If needed, dose can be increased to a maximum of 5 mL once daily or 2.5 mL every                   12 hours. Do not give more than 5 mL in 24 hours
    children under 2 years of age
    		ask a doctor
    consumers with liver or kidney disease
    		ask a doctor

  • Other Information

    • store between 20° to 25°C (68° to 77°F)
    • do not use if carton is opened or bottle wrap imprinted “SAFETY SEAL®” is broken or missing
    • see top panel for lot number and expiration date
  • Inactive ingredients

    anhydrous citric acid, flavors, non crystallizing sorbitol solution, propylene glycol, purified water, sodium benzoate and sucralose.

  • Questions?

    call 1-888-588-1418
                                                  
    Distributed by:
    Camber Consumer Care, Inc.
    Piscataway, NJ 08854, USA.

    Mfg. Lic. No.: 22/RR/AP/2001/F/R



  • cetirizine hydrochloride

    Label Image
  • INGREDIENTS AND APPEARANCE
    CHILDRENS ALLERGY RELIEF 
    cetirizine hydrochloride solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50090-4741(NDC:69230-316)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24) CETIRIZINE HYDROCHLORIDE1 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    SORBITOL (UNII: 506T60A25R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    Product Characteristics
    ColorYELLOW (Colorless to Yellow) Score    
    ShapeSize
    FlavorGRAPEImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:50090-4741-01 in 1 CARTON11/21/2019
    1118 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21062203/13/2019
    Labeler - A-S Medication Solutions (830016429)
    Establishment
    NameAddressID/FEIBusiness Operations
    A-S Medication Solutions830016429RELABEL(50090-4741)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!